GlassScriptPhysician profile
Pam Ferolie
NPI 1184788648
$837.44
in general payments reported to CMS, 2019-2025
13 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $25.58 · 2024: $413 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $117.97 | 2024 | Arexvy, Shingrix |
| Exact Sciences Corporation | $106.20 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $101.60 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $73.62 | 2024-2025 | Rexulti |
| Pfizer INC. | $68.21 | 2024-2025 | |
| Inspire Medical Systems, INC. | $67.09 | 2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.22 | 2024-2025 | Xifaxan |
| Philips North America LLC | $60.69 | 2024-2025 | (Ck7) Extended Holter, Extended Holter |
| Gilead Sciences, INC. | $58.40 | 2024-2025 | |
| Hologic Sales and Service, LLC | $47.79 | 2024-2025 | Aptima |
| Viiv Healthcare Company | $31.12 | 2025 | Apretude |
| Sanofi-Aventis U.S. LLC | $21.66 | 2024 | |
| Phadia US INC. | $20.87 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pam Ferolie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.